Newsflash:
- Many Drug Labels Missing Dose, Safety Info for Kids
- Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer
- J&J Opens Doxil Rationing Program to New Patients
- FDA Issues Safety Label Changes for Fingolimod
- FDA Backs Pill to Block HIV Infection
- FDA Advisers Recommend Approving Arena Weight-Loss Drug
DePuy Orthopaedics Receives FDA PMA Supplement Approval for TRUMATCH Personalized Solutions with SIGMA Rotating Platform Knee System
Johnson & Johnson Press Release (02/15/12)
DePuy Orthopaedics, a Johnson & Johnson company, has received Premarket Supplement Approval from FDA for use of TRUMATCH Personalized Solutions with DePuy’s SIGMA RP Knee System. TRUMATCH Solutions for use with DePuy’s SIGMA Fixed Bearing Knee System was previously cleared in August 2011, making DePuy the only orthopaedic company to have personalized instrumentation for use with both rotating platform and fixed bearing knees.
Abstract News © Copyright 2011
INFORMATION, INC.
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
